SCHEMBL4440962

SCHEMBL4440962

CCC1(C)CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3376771 0.97 KDM4E (0.37)
SCHEMBL13062883 0.90 KDM4E (0.33)
SCHEMBL26492354 0.88 ALDH1A1 (0.35)
SCHEMBL17177200 0.83
SCHEMBL17176301 0.83
SCHEMBL12853651 0.83
SCHEMBL24220726 0.81 TSHR (0.36)
SCHEMBL14860689 0.78 HSD17B10 (0.31)
SCHEMBL5756962 0.77
SCHEMBL613348 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12528948-B2 Amino (meth)acrylates ALLNEX BELGIUM S.A. (BE) 2026-01-20 US disclosed
US-20240359168-A1 Mesoporous Catalyst Compounds and Uses Thereof EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2024-10-31 US disclosed
CN-118834313-A Zwitterionic polymer, ion exchange membrane, and preparation methods and applications thereof 佛山绿动氢能科技有限公司 2024-10-25 CN disclosed
EP-3630770-B1 PYRAZOLO[3,4-B]PYRAZINE DERIVATIVES AS SHP2 PHOSPHATASE INHIBITORS RELAY THERAPEUTICS INC (US) 2024-08-28 EP disclosed
US-12064752-B2 Mesoporous catalyst compounds and uses thereof ExxonMobil Technology and Engineering Company (US) 2024-08-20 US disclosed
CN-117720721-B Anion exchange polymer, ion exchange membrane, and preparation methods and application thereof 国家电投集团氢能科技发展有限公司 2024-04-30 CN disclosed
CN-117720721-A Anion exchange polymer, ion exchange membrane, and preparation methods and application thereof 国家电投集团氢能科技发展有限公司 2024-03-19 CN disclosed
US-11911369-B2 Prodrugs of riluzole and their method of use BIOHAVEN THERAPEUTICS LTD. (VG) 2024-02-27 US disclosed
CN-117487047-A Phosphonic acid functionalized polymer, multifunctional styrene polymer and application thereof 国家电投集团氢能科技发展有限公司 2024-02-02 CN disclosed
EP-3628044-B1 PYRROLO[2,3-C]PYRIDINES AND RELATED ANALOGS AS LSD-1 INHIBITORS UNIV MICHIGAN REGENTS (US) 2023-11-22 EP disclosed
US-20100216770-A1 Inhibitors of the Interaction Between MDM2 and P53 JANSSEN-CILAG (FR) 2010-08-26 US disclosed
US-20100130465-A1 2-AMINOTHIAZOLE-4-CARBOXYLIC AMIDES AS PROTEIN KINASE INHIBITORS MERCK SHARP & DOHME LLC 2010-05-27 US disclosed
EP-2121656-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE Pfizer Products Inc. (US) 2009-11-25 EP disclosed
WO-2009037343-A1 INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53 JANSSEN PHARMACEUTICA NV (BE) 2009-03-26 WO disclosed
US-20080287479-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER INC 2008-11-20 US disclosed
WO-2008084300-A1 INHIBITORS OF SERINE PALMITOYLTRANSFERASE PFIZER PRODUCTS INC. (US) 2008-07-17 WO disclosed
US-20070219206-A1 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS AMIRA PHARMACEUTICALS, INC. (US) 2007-09-20 US disclosed
US-20070185168-A1 Piperidine derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-08-09 US disclosed
US-5382590-A Gastrointestinal disorders and nervous system disorders RHONE-POULENC RORER S.A. (FR) 1995-01-17 US disclosed
US-4680402-A Benzoyl-phenyl-piperidine derivatives SOCIETE DE RECHERCHES INDUSTRIELLES (S.O.R.I.) (FR) 1987-07-14 US disclosed